𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Two monoclonal anti-CD3 antibodies can induce different events in human T lymphocyte activation

✍ Scribed by Eddy E. Roosnek; René A. van Lier; Lucien A. Aarden

Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
442 KB
Volume
17
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Two different anti-erythroid monoclonal
Two different anti-erythroid monoclonal antibodies in immunodiagnosis of human leukemias: A comparative study
✍ N. N. Tupitsyn; E. B. Mechetner; A. Ju. Baryschnikov; T. S. Drozdova; M. A. Fren 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 408 KB

To date, only anti-glycophorin-A monoclonal antibodies (MAbs) have been widely used as anti-erythroid probes in the diagnosis of leukemias. We have examined blood, bonemarrow and lymph-node samples from 474 patients, adults and children, with different hemopoietic malignancies, using a panel of MAbs

Anti-CD3-based bispecific antibody desig
Anti-CD3-based bispecific antibody designed for therapy of human B-cell malignancy can induce T-cell activation by antigen-dependent and antigen-independent mechanisms
✍ Brian K. Link; Sheri A. Kostelny; Michael S. Cole; William P. Fusselman; J. Yun 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 107 KB 👁 2 views

## Anti -CD3 ؋ anti-B-cell antigen bispecific monoclonal antibodies (bsAbs) can redirect T-cell-mediated lysis toward malignant B cells. Clinical trials with CD3-based bsAbs have shown toxicity in patients which is likely related to nonspecific T-cell activation and targeting. Our current studies